Mycobacterium bovis bacille Calmette-Guerin enhances pathogenicity of simian immunodeficiency virus infection and accelerates progression to AIDS in macaques: A role of persistent T cell activation in AIDS pathogenesis

Journal of Immunology

Volumn 162, Issue 4, 1999, Pages 2204-2216

  Zhou, Dejiang ^a   Shen, Yun ^a   Chalifoux, Laura ^b   Lee Parritz, David ^b   Simon, Meredith ^b   Sehgal, Prabhat K ^b   Zheng, Leiya ^a   Halloran, Matilda ^a   Chen, Zheng W ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b New England Primate Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL MODEL; ARTICLE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; LYMPHOCYTE COUNT; MACACA; MYCOBACTERIUM BOVIS; NONHUMAN; PATHOGENESIS; PATHOGENICITY; PRIORITY JOURNAL; SHOCK; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; LYMPHOCYTE ACTIVATION; MACACA MULATTA; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM BOVIS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTE SUBSETS; TUBERCULOSIS;

EID: 0033558131     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Raviglione, M. C., J. P. Narain, and A. Kochi. 1992. HIV-associated tuberculosis in developing countries: clinical features, diagnosis, and treatment. Bull. World Health Organ. 70:515.
2. Dolin, P. J., M. C. Raviglione, and A. Kochi. 1994. Global tuberculosis incidence and mortality during 1990-2000. Bull. World Health Organ. 72:231.
3. Raviglione, M. C., D. E. Snider, Jr., and A. Kochi. 1995. Globe epidemiology of tuberculosis: morbidity and mortality of worldwide epidemic. JAMA 273:220.
4. Daley, C., P. Small, G. F. Schecter, G. K. Schoolnik, R. A. McAdam, W. R Jacobs, and P. C. Hopewell. 1992. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. N. Engl. J. Med. 326:231.
5. Villiarino, M. E., S. W. Dooley, K. G. Geiter, K. G. Castro, and D. E. Snider, Jr. 1992. Management of persons exposed to multidrug-resistant tuberculosis and progression of HIV infection. Morb. Mortal. Wkly. Rep. 41(RR-11):61.
6. Selwyn, P. A., D. Hartel, V. A. Lewis, E. E. Schoenbaum, S. H. Vermund, R. S. Klein, A. T. Walker, and G. H. Freidland. 1989. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N. Engl. J. Med. 320:545.
7. Small, P. M., P. C. Hopewell, S. P. Singh, A. Paz, J. Pasonnet, D. C. Ruston, G. F. Schecter, C. L. Daley, and G. K. Schoolnik. 1994. The epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular method. N. Engl. J. Med. 330:1703.
8. Barnes, P. F., A. B. Bloch, P. T. Davidson, and D. E. Snider, Jr. 1991. Tuberculosis in patients with human immunodeficiency virus infection. N. Engl. J. Med. 324:1644.
9. Whalen, C., C. R. Horsburgh, D. Hom, C. Lahart, M. Simberkoff, and J. Eller. 1995. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am. J. Respir. Crit. Care Med. 151:129.
10. Pape, J. W., S. S. Jean, L. Ho, A. Haffner, and D. W. Johnson, Jr. 1993. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 342:268.
11. Shattock, R. J., J. S. Friedland, and G. E. Griffin. 1993. Modulation of HIV transcription in and release frome monocytic cells following phagocytosis of Mycobacterium tuberculosis. Res. Virol. 144:7.
12. Zhang, Y., K. Nakata, M. Weiden, and W. M. Rom. 1995. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repert. J. Clin. Invest. 95:2324.
13. Goletti, D., D. Weissman, R. W. Jackson, N. M. Graham, D. Vlahov, R. S. Klein, S. S. Munsiff, L. Ortona, R. Cauda, and A. S. Fauci. 1996. Effect of Mycobacterium tuberculosis on HIV replication: role of immune activation. J. Immunol. 157:1271.
14. Garrait, V., J. Cadranel, H. Esvant, I. Herry, P. Morinet, C. Mayaud, and D. Israel-Biet. 1997. Tuberculosis generates a microenvironment enhancing the productive infection of local lymphocytes by HIV J. Immunol. 159:2824.
15. Morris, L., D. J. Martin, L. Sacks, S. Pendle, L. Page-Shipp, H. Bredell. T. C. Quinn, and R. E. Chaisson. 1998. Persistent elevation of HIV viral loads during therapy for tuberculosis. In Abstracts of the 5th Conference on Retroviruses and Opportunistic Infections, p. 259.
16. Letvin, N. L., and N. W. King. 1990. Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. AIDS 1:1023.
17. Desrosiers, R. C. 1990. The simian immunodeficiency viruses. Annu. Rev. Immunol. 8:557.
18. Letvin, N. L. 1990. Animal models for AIDS. Immunol. Today 11:322.
19. Chen, Z. W., Z. Kou, L. Shen, K. A. Reimann, and N. L. Letvin. 1993. Conserved T cell receptor repertoire in simian immunodeficiency virus-infected rhesus monkeys. J. Immunol. 151:2177.
20. Chen, Z. W., L. Shen, M. D. Miller, S. H. Ghim, A. L. Hughes, and N. L. Letvin. 1992. Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian of immunodeficiency virus gag. J. Immunol. 149:4060.
21. Chen, Z. W., H. Yamamoto, D. I. Watkins, G. Levinson, and N. L. Letvin. 1992. A predominant use of a T cell receptor Vβ gene family in SIV gag-specific cytotoxic T lymphocytes in a rhesus monkey. J. Virol. 66:3913
22. Chen, Z. W., Z. Kou, L. Shen, J. D. Regan, C. I. Lord, M. Halloran, D. Lee-Parritz, P. N. Fultz, and N. L. Letvin. 1994. An acutely lethal simian immunodeficiency virus stimulates expansion of Vβ 7- and Vβ 14-expressing T lymphocytes. Proc. Natl. Acad. Sci. USA 91:7501.
23. Chen, Z. W., Z. Kou, C. Lekutis, L. Shen, D. Zhou, M. Halloran, J. Li, J. Sodroski, D. Lee-Parritz, and N. L. Letvin. 1995. T cell receptor Vβ repertoire in an acute infection of rhesus monkeys with simian immunodeficiency viruses and a chimeric simian-human immunodeficiency virus. J. Exp. Med. 182:21.
24. Chen, Z. W., L. Shen, J. D. Regan, Z. Kou, and N. L. Letvin. 1996. The T cell receptor gene usage by simian immunodeficiency virus gag-specific cytotoxic T lymphocytes. J. Immunol. 156:1469.
25. Chen, Z. W., D. Zhou, L. Chalifoux, D. Lee-Parritz, and N. L. Letvin. 1997. Desseminated granulomatous disease in a SIVmac- and BCG-infected rhesus monkey. AIDS 11:266.
26. Kou, Z., M. Halloran, D. Lee-Parritz, L. Shen, M. Simon, P. K. Sehgal, Y. Shen, and Z. W. Chen. In vivo effects of a bacterial superantigen on macaque T cell receptor repertoires. 1998. J. Immunol. 160:5170.
27. Polyak, S., H. Chen, D. Hirsch, I. George, R. Hershberg, and K. Sperber. 1997. Impaired class II expression and antigen uptake in monocytic cells after HIV-1 infection. J. Immunol. 159:2177.
28. + T cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat. Med. 3: 533.
29. Piatak, M., K. Luk, B. Williams, and J. D. Lifson. 1993. Quantitative competitive polymerase chain reaction for accurate quanlitation of HIV DNA and RNA species. Biotechniques 14:70.
30. Saksela, K., E. Muchmore, M. Girard, P. N. Fultz, and D. Baltimore. 1993. High viral load in lymph nodes and latent human immunodeficiency virus (HIV) in peripheral blood cells of HIV-1-infected chimpanzees. J. Virol. 67:7423.
31. Dunn, O. J., and V. A. Clark. 1987. Applied Statistics: Analysis of Variance and Regression, 2nd Ed., Wiley Interscience, New York, p. 214.
32. Sunderam, G., R. J. McDonald, T. Maniatis, J. Oleske, R. Kapila, and L. B. Reichman. 1986. Tuberculosis as a manifestation of the AIDS. JAMA 256: 362.
33. Orme, IM. 1988. Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection. J. Immunol. 140:35989.
34. Toossi, E., and J. J. Ellner. 1996. Mechanisms of anergy in tuberculosis. Curr. Top. Microbiol. Immunol. 221:239.
35. Fultz, P. N., J. C. Gluckman, E. Muchmore, and M. Girard. 1992. Transient increases in numbers of infectious cells in an HIV-infected chimpanzee following immune stimulation. AIDS Res. Hum. Retroviruses 8:313.
36. Staprans, S. I., B. L. Hamilton, S. E. Follansbee, T. Elbeik, P. Barbosa, R. M. Grant, and M. B. Feinberg. 1995. Activation of virus replication after vaccination of HIV-1-infected individuals. J. Exp. Med. 182:1727.
37. Stanley, S. K., M. A. Ostrowski, J. S. Justement, K. Gantt, S. Hedayati, M. Mannix, K. Roche, D. J. Schwartzentruber, C. H. Fox, and A. S. Fauci. 1996. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N. Engl. J. Med. 334:1222.
38. O'Brien, W. A., K. Grovit-Ferbas, A. Namazi, S. Ovcak-Derzic, H. J. Wang, J. Park, C. Yeramian, S. H. Mao, and J. A. Zack. 1995. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 86:1082.
39. Cheynier, R., S. Gratton, M. Halloran, I. Stahmer, N. Letvin, and S. Wain-Hobson. 1998. Antigenic stimulation by BCG vaccine as an in vivo driving force for SIV replication and dissemination. Nat. Med. 4:421.
40. Ostrowski, M. A., D. Krakuer, Y. Li, S. J. Justement, and A. S. Fauci. 1998. The effect of tetanus immunization on HIV-1 quasispecies dynamics. In Fifth Conference on Retroviruses and Opportunistic Infections, p. 129.
41. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. Mackay, G. LaRosa, W. Newman, N. Gerard, C. Gerard, and J. Sodroski 1996. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135.
42. Hill, C. M., H. Deng, D. Unutmaz, Y. N. Kewalramani, L. Bastiani, M. K. Gorny, S. Zolla-Pazner, and D. R. Littman. 1997. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor. J. Virol. 71:6296.
43. Rosenberg, Z. F., and A. S. Fauci. 1990. Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunol. Today 11:176.
44. Orenstein, J. M., C. Fox, and S. M. Wahl. 1997. Macrophages as a source of HIV during opportunistic infections. Science 276:1857.
45. Jiorgi, J. N. 1996. Phenotype and function of T cells in HIV disease. 1996. Immunology of HIV Infection. S. Gupta, ed. Plenum Press, New York, pp. 181-198.
46. Guide for the Care and Use of Laboratory Animals. 1996. National Academy Press, Washington, DC.